Autres langues SciSparc Ltd.

Actions

SPRC

IL0010951403

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 14/05/2024			Varia. 5j.	Varia. 1 janv.
1,25 ^USD	0,00 %		+3,31 %	-74,39 %

01/04	SciSparc Ltd. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
18/03	SciSparc Ltd. reçoit un autre brevet, renforçant ainsi sa technologie de base au Canada	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SciSparc to Acquire AutoMax	11/04
SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd.	11/04
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research	21/03
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Ltd. Receives Another Patent, Strengthening its Core Technology in Canada	18/03
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial	14/03
SciSparc Ltd. Announces Successfully Dosed the First Patient in Its SCI-210 Clinical Trial At the Soroka Medical Center for Pediatric Patients	14/03
SciSparc : MitoCareX Update - Form 6-K	13/03
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	12/03
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure	12/03
Top Premarket Gainers	08/03
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	08/03
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder	08/03
SciSparc Ltd. Announces Enrollment of First Patient for Its Clinical Trial for Children with Autism Spectrum Disorder	08/03
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07/03
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07/03
Scisparc Ltd. Granted Patent for Core Technology in Multiple Jurisdictions in Europe	07/03
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology	06/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SciSparc Ltd.

Actions

SPRC

IL0010951403

Autres langues

Filtres